The “AI&BM for Leukemia” project – Artificial Intelligence and Biophotonic Microscopy for rapid and early tests on leukaemia cells
A new biophotonic microscopy-based technology to accelerate and simplify the diagnosis and monitoring of patients with leukaemia, with significant time- and cost-savings to benefit individual health and the operation of the healthcare system
Many of the most recent advances in biomedical research are associated with the identification of new methods for studying cells. The combined application of modern technologies results in considerable reductions in the time required to analyse and classify certain cells, thereby revolutionising the systems used to diagnose a number of diseases. The “AI&BM for Leukemia” project – proposed by the University of Ferrara and Plastic Jumper and funded by the IFAB Foundation – intends to develop a new system for the early diagnosis of leukaemia and its monitoring in the therapy and post-therapy phases. The new system aims to overcome some of the limits of current diagnostic practices based on specialised laboratory testing, in order to simplify and expedite analysis and study the effectiveness of treatments in a non-invasive and highly accurate manner.